Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
CardiologycardiomyopathyDemographics and Epidemiology of Sudden Deaths in Young Competitive Athletes (video)

Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes (video)

sprinter on their mark ready to run

 

Sudden deaths in young, seemingly healthy competitive athletes are tragic events, often with wide media coverage and high public visibility. There is substantial interest in establishing the cause of these deaths and the roles that race and gender may play. In a new study published in The American Journal of Medicine, investigators report that more than one-third of recorded cardiovascular deaths were caused by hypertrophic cardiomyopathy, the majority in young male minority athletes. Sudden deaths due to genetic and/or congenital heart diseases are uncommon in females, but relatively common in African-American and other minorities compared to whites.

Researchers accessed the U.S. National Registry of Sudden Death in Athletes, 1980-2011 to define the epidemiology and causes of sudden deaths in competitive athletes. More than 2,400 deaths were identified in young athletes aged between 13 and 25 years engaged in 29 different sports. Over 840 athletes had cardiovascular diagnoses confirmed at autopsy.

ā€œUtilizing this registry, we have established that hypertrophic cardiomyopathy is the leading cause of sudden cardiac death in male athletes and is an under-appreciated cause of sudden death in male African-American and minority athletes, but is a rare cause of death in female athletes,ā€ explained lead investigator Barry J. Maron, MD, Tufts Medical Center, HCM Institute, Division of Cardiology, Boston, MA.

The investigators found that:

  • Male athletes were 6.5 times more likely to die from a sudden cardiac event than females.
  • More than one-third of deaths were caused by hypertrophic cardiomyopathy, which accounted for nearly 40% of male sudden deaths and was almost four times more common in males than females.
  • Cardiovascular death rate among African-Americans and other minorities exceeded whites almost five-fold.
  • Among cases of hypertrophic cardiomyopathy, more than 50% occurred in minority males, but only 1% in minority females.
  • Sudden deaths among male and female basketball players were three times more likely to be African-American and minorities than white.
  • Congenital coronary artery anomalies, arrhythmogenic right ventricular cardiomyopathy, and clinically diagnosed long-QT syndrome were more frequent among females.
  • Structurally normal hearts comprised less than 5% of athlete deaths.

Hypertrophic cardiomyopathy is a disease of the myocardium (heart muscle) in which a portion of the myocardium is hypertrophied (thickened) without any obvious cause, creating functional impairment of the cardiac muscle. It is a significant cause of sudden unexpected cardiac death in any age group and as a cause of disabling cardiac symptoms. There are often no symptoms beforehand.

ā€œThese observations underscore the potential value of the American Heart Association/American College of Cardiology recommended preparticipation screening in minority and other communities, particularly for the identification of hypertrophic cardiomyopathy,ā€ Dr. Maron added.

 

Read the research:

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many ā€œmiracles of modern medicine.ā€ Reliance on the ā€œinvisible handā€ of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...